Carbamazepine-induced toxic epidermal necrolysis: the importance of HLA-B*1502 testing in at-risk populations prior to therapy initiation

Int J Dermatol. 2021 Jul;60(7):907-908. doi: 10.1111/ijd.15461. Epub 2021 Feb 19.

Authors

Brynn Sargent¹, Margit L W Juhasz², Victor C Joe³, Bonnie A Lee², Nathan W Rojek²

Affiliations

¹ School of Medicine, University of California, Irvine, CA, USA.
² Department of Dermatology, University of California, Irvine, CA, USA.
³ Department of Surgery, University of California, Irvine, CA, USA.

PMID: 33608873
DOI: 10.1111/ijd.15461

No abstract available

Publication types

Letter

MeSH terms

Anticonvulsants / adverse effects
Asian People
Carbamazepine / adverse effects
HLA-B Antigens / genetics
HLA-B15 Antigen / genetics
Humans
Stevens-Johnson Syndrome* / etiology
Stevens-Johnson Syndrome* / genetics

Substances

Anticonvulsants
HLA-B Antigens
HLA-B15 Antigen
Carbamazepine